Colostrinin™: An oxidative stress modulator for prevention and treatment of age-related disorders

Journal of Alzheimer's Disease

Volumn 13, Issue 3, 2008, Pages 303-321

  Boldogh, Istvan ^b   Kruzel, Marian L ^a  

^a PharmaReview Corporation   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Age related disorders; Alzheimer's disease; Amyloid ; Immunomodulation; Oxidative stress; Proline rich polypeptide

Indexed keywords

CHOLINESTERASE INHIBITOR; COLOSTRININ; DONEPEZIL; GALANTAMINE; GINKGO BILOBA EXTRACT; MEMANTINE; METRIFONATE; NONSTEROID ANTIINFLAMMATORY AGENT; PEPTIDE; POLYPEPTIDE; RIVASTIGMINE; SELENIUM; TACRINE; VACCINE; VALYLGLUTAMYLSERYLTYROSYLVALYLPROLYLLEUCYLPHENYLALANYLPROLINE; ANTIOXIDANT; COLOSTRININE; GLUTATHIONE; REACTIVE OXYGEN METABOLITE;

ALLERGIC INFLAMMATION; ALZHEIMER DISEASE; ANOREXIA; ANXIETY; APOPTOSIS; BIOLOGICAL ACTIVITY; BLEEDING; CELL SURVIVAL; COMA; DIARRHEA; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG MECHANISM; GENE MUTATION; GERIATRIC DISORDER; HOMEOSTASIS; HUMAN; INFLAMMATION; INSOMNIA; LEARNING; LIFESPAN; LOGORRHEA; MEMORY; MULTIPLE CYCLE TREATMENT; NAUSEA; NERVE FIBER GROWTH; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SEIZURE; SIDE EFFECT; SIGNAL TRANSDUCTION; VOMITING; AGING; ANIMAL; DISEASE MODEL; DRUG EFFECT; MITOCHONDRION; MOUSE; PSYCHOMOTOR PERFORMANCE;

AGING; ALZHEIMER DISEASE; ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; GLUTATHIONE; HUMANS; MICE; MITOCHONDRIA; OXIDATIVE STRESS; PEPTIDES; PSYCHOMOTOR PERFORMANCE; REACTIVE OXYGEN SPECIES;

EID: 47849130514     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2008-13308     Document Type: Review

References (142)

1. E.I. Agorogiannis, G.I. Agorogiannis, A. Papadimitriou and G.M. Hadjigeorgiou, Protein misfolding in neurodegenerative diseases, Neuropathol Appl Neurobiol 30 (2004), 215-224.
2. P.S. Aisen, K.L. Davis, J.D. Berg, K. Schafer, K. Campbell, R.G. Thomas, M.F. Weiner, M.R. Farlow, M. Sano, M. Grundman and L.J. Thal, A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study, Neurology 54 (2000), 588-593.
3. T. Albrecht, M.P. Fons, C.Z. Deng and I. Boldogh, Increased frequency of specific locus mutation following human cytomegalovirus infection, Virology 230 (1997), 48-61.
4. R. Aloni-Grinstein, I. Zan-Bar, I. Alboum, N. Goldfinger and V. Rotter, Wild type p53 functions as a control protein in the differentiation pathway of the B-cell lineage, Oncogene 8 (1993), 3297-3305.
5. A. Bacsi, L. Aguilera-Aguirre, P. German, M.L. Kruzel and I. Boldogh, Colostrinin decreases spontaneous and induced mutation frequencies at the hprt locus in Chinese hamster V79 cells, J Exp Ther Oncol 5 (2006), 249-259.
6. A. Bacsi, B.K. Choudhury, N. Dharajiya, S. Sur and I. Boldogh, Subpollen particles: carriers of allergenic proteins and oxidases, J Allergy Clin Immunol 118 (2006), 844-850.
7. A. Bacsi, N. Dharajiya, B.K. Choudhury, S. Sur and I. Boldogh, Effect of pollen-mediated oxidative stress on immediate hypersensitivity reactions and late-phase inflammation in allergic conjunctivitis, J Allergy Clin Immunol 116 (2005), 836-843.
8. A. Bacsi, G.J. Stanton, T.K. Hughes, M. Kruze and I. Boldogh, Colostrinin-driven neurite outgrowth requires p53 activation in PC12 cells, Cell Mol Neurobiol 25 (2005), 1123-1139.
9. A. Bacsi, M. Woodberry, M.L. Kruzel and I. Boldogh, Colostrinin delays the onset of proliferative senescence of diploid murine fibroblast cells, Neuropeptides 41 (2007), 93-101.
10. A. Bacsi, M. Woodberry, W. Widger, J. Papaconstantinou, S. Mitra, J.W. Peterson and I. Boldogh, Localization of superoxide anion production to mitochondrial electron transport chain in 3-NPA-treated cells, Mitochondrion 6 (2006), 235-244.
11. M.F. Beal, Mitochondria take center stage in aging and neurodegeneration, Ann Neurol 58 (2005), 495-505.
12. L.I. Benowitz and A. Routtenberg, GAP-43: an intrinsic determinant of neuronal development and plasticity, Trends Neurosci 20 (1997), 84-91.
13. C. Berndt, C.H. Lillig and A. Holmgren, Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system, Am J Physiol Heart Circ Physiol 292 (2007), H1227-H1236.
14. A. Bilikiewicz and W. Gaus, Colostrinin (a naturally occurring, proline-rich, polypeptide mixture) in the treatment of Alzheimer's disease, J Alzheimers Dis 6 (2004), 17-26.
15. I. Boldogh, A. Bacsi, L. Agulera-Aguirre, P. German and M. Kruzel, Colostrinin™ Increases the Lifespan and Neurological Performance of Mice, Neurodegener Dis 4 (Suppl 1) (2007), 264.
16. I. Boldogh, A. Bacsi, B.K. Choudhury, N. Dharajiya, R. Alam, T.K. Hazra, S. Mitra, R.M. Goldblum and S. Sur, ROS generated by pollen NADPH oxidase provide a signal that augments antigen-induced allergic airway inflammation, J Clin Invest 115 (2005), 2169-2179.
17. I. Boldogh, T.K. Hughes, J.A. Georgiades and J. Stanton, Antioxidant and cell-differentiating activity of colostrinin and its component peptides (CCP) in cell culture, Psychogeriatr Ann 4 (2001), 57-65.
18. I. Boldogh, T.K. Hughes, J.A. Georgiades and J. Stanton, Antioxidant and nerve differentiating activity of colostrinine and related peptides. In: J. Georgiades, editor; 2000 December 1, 2000; Lodz, Poland.
19. I. Boldogh, L. Aguilera-Aguirre, A. Bacsi, B.K. Choudhury, A. Saavedra-Molina and M. Kruzel. Colostrinin decreases hypersensitivity and allergic responses to common allergens, Int Arch Allergy Immunol (2008), In press.
20. I. Boldogh, D. Liebenthal, T.K. Hughes, T.L. Juelich, J.A. Georgiades, M.L. Kruzel and G.J. Stanton, Modulation of 4HNE-mediated signaling by proline-rich peptides from ovine colostrum, J Mol Neurosci 20 (2003), 125-134.
21. M. Bourhim, M. Kruzel, T. Srikrishnan and T. Nicotera, Linear quantitation of Abeta aggregation using Thioflavin T: reduction in fibril formation by colostrinin, J Neurosci Methods 160 (2007), 264-268.
22. J. Bousquet, Global initiative for asthma (GINA) and its objectives, Clin Exp Allergy 30(Suppl 1) (2000), 2-5.
23. J. Campisi, Replicative senescence: an old lives' tale? Cell 84 (1996), 497-500.
24. J. Campisi, S.H. Kim, C.S. Lim and M. Rubio, Cellular senescence, cancer and aging: the telomere connection, Exp Gerontol 36 (2001), 1619-1637.
25. S.B. Carbonare, M.L. Silva, P. Palmeira and M.M. Carneiro-Sampaio, Human colostrum IgA antibodies reacting to enteropathogenic Escherichia coli antigens and their persistence in the faeces of a breastfed infant, J Diarrhoeal Dis Res 15 (1997), 53-58.
26. D.M. Carlson, Salivary proline-rich proteins: biochemistry, molecular biology, and regulation of expression, Crit Rev Oral Biol Med 4 (1993), 495-502.
27. E. Check, Nerve inflammation halts trial for Alzheimer's drug, Nature 415 (2002), 462.
28. J.Z. Cheng, S.S. Singhal, M. Saini, J. Singhal, J.T. Piper, F.J. Van Kuijk, P. Zimniak, Y.C. Awasthi and S. Awasthi, Effects of mGST A4 transfection on 4-hydroxynonenal-mediated apoptosis and differentiation of K562 human erythroleukemia cells, Arch Biochem Biophys 372 (1999), 29-36.
29. D.A. Clare and H.E. Swaisgood, Bioactive milk peptides: a prospectus, J Dairy Sci 83 (2000), 1187-1195.
30. A.C. Collier, K.L. Pritsos and C.A. Pritsos, TCDD as a biological response modifier for Mitomycin C: oxygen tension affects enzyme activation, reactive oxygen species and cell death, Life Sci 78 (2006), 1499-1507.
31. J.L. Cummings, Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations, Am J Geriatr Psychiatry 11 (2003), 131-145.
32. G. D'Arcangelo and S. Halegoua, A branched signaling pathway for nerve growth factor is revealed by Src-, Ras-, and Raf-mediated gene inductions, Mol Cell Biol 13 (1993), 3146-3155.
33. A. Das, T.K. Hazra, I. Boldogh, S. Mitra and K.K. Bhakat, Induction of the human oxidized base-specific DNA glycosylase NEIL1 by reactive oxygen species, J Biol Chem 280 (2005), 35272-35280.
34. F. de Blay, G. Pauli, M. Velten and J.C. Bessot, Influence of mite exposure on symptoms of mite-sensitive patients with asthma, J Allergy Clin Immunol 93 (1994), 136-138.
35. F.R. de Gruijl, H.J. Sterenborg, P.D. Forbes, R.E. Davies, C. Cole, G. Kelfkens, H. van Weelden, H. Slaper and J.C. van der Leun, Wavelength dependence of skin cancer induction by ultraviolet irradiation of albino hairless mice, Cancer Res 53 (1993), 53-60.
36. L.L. de Zwart, J.H. Meerman, J.N. Commandeur and N.P. Vermeulen, Biomarkers of free radical damage applications in experimental animals and in humans, Free Radic Biol Med 26 (1999), 202-226.
37. C.M. Deaton, The role of oxidative stress in an equine model of human asthma, Redox Rep 11 (2006), 46-52.
38. L. Esposito, J. Raber, L. Kekonius, F. Yan, G.Q. Yu, N. Bien-Ly, J. Puolivali, K. Scearce-Levie, E. Masliah and L. Mucke, Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice, J Neurosci 26 (2006), 5167-5179.
39. H. Esterbauer, R.J. Schaur and H. Zollner, Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes, Free Radic Biol Med 11 (1991), 81-128.
40. A.A. Farooqui and L.A. Horrocks, Phospholipase A2-generated lipid mediators in the brain: the good, the bad, and the ugly, Neuroscientist 12 (2006), 245-260.
41. M. Ferguson, R.J. Mockett, Y. Shen, W.C. Orr and R.S. Sohal, Age-associated decline in mitochondrial respiration and electron transport in Drosophila melanogaster, Biochem J 390 (2005), 501-511.
42. J.M. Fessenden, W. Wittenborn and L. Clarke, Gingko biloba: a case report of herbal medicine and bleeding postoperatively from a laparoscopic cholecystectomy, Am Surg 67 (2001), 33-35.
43. F.D. Finkelman, I.M. Katona, T.R. Mosmann and R.L. Coffman, IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses, J Immunol 140 (1988), 1022-1027.
44. M.J. Forster, A. Dubey, K.M. Dawson, W.A. Stutts, H. Lal and R.S Sohal, Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain, Proc Natl Acad Sci USA 93 (1996), 4765-4769.
45. S. Galluzzi, O. Zanetti, G. Binetti, M. Trabucchi and G.B. Frisoni, Coma in a patient with Alzheimer's disease taking low dose trazodone and gingko biloba, J Neurol Neurosurg Psychiatry 68 (2000), 679-680.
46. A.A. Galoyan, J.S. Sarkissian, T.K. Kipriyan, E.J. Sarkissian, E.A. Chavushyan, R.M. Sulkhanyan, I.B. Meliksetyan, S.S. Abrahamyan, Y.K.h. Grigorian, Z.A. Avetisyan and N.A. Otieva, Protective effect of a new hypothalamic peptide against cobra venom and trauma-induced neuronal injury, Neurochem Res 26 (2001), 1023-1038.
47. T.C. Gamblin, F. Chen, A. Zambrano, A. Abraha, S. Lagalwar, A.L. Guillozet, M. Lu, Y. Fu, F. Garcia-Sierra, N. La-Pointe, R. Miller, R.W. Berry, L.I. Binder and V.L. Cryns, Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease, Proc Natl Acad Sci USA 100 (2003), 10032-10037.
48. A. Gladkevich, F. Bosker, J. Korf, K. Yenkoyan, H. Vahradyan and M. Aghajanov, Proline-rich polypeptides in Alzheimer's disease and neurodegenerative disorders - Therapeutic potential or a mirage? Prog Neuropsychopharmacol Biol Psychiatry 31 (2007), 1347-1355.
49. D. Hanahan and R.A. Weinberg, The hallmarks of cancer, Cell 100 (2000), 57-70.
50. L.A. Hanson, Breastfeeding provides passive and likely long-lasting active immunity, Ann Allergy Asthma Immunol 81 (1998), 523-533; quiz 533-524, 537.
51. J. Hardy and D.J. Selkoe, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science 297 (2002), 353-356.
52. S.L. Harris and A.J. Levine, The p53 pathway: positive and negative feedback loops, Oncogene 24 (2005), 2899-2908.
53. P.E. Hockberger, T.A. Skimina, V.E. Centonze, C. Lavin, S. Chu, S. Dadras, J.K. Reddy and J.G. White, Activation of flavin-containing oxidases underlies light-induced production of H2O2 in mammalian cells, Proc Natl Acad Sci USA 96 (1999), 6255-6260.
54. M. Hosang and E.M. Shooter, The internalization of nerve growth factor by high-affinity receptors on pheochromocytoma PC12 cells, EMBO J 6 (1987), 1197-1202.
55. M. Hosokawa, A higher oxidative status accelerates senescence and aggravates age-dependent disorders in SAMP strains of mice, Mech Ageing Dev 123 (2002), 1553-1561.
56. E. Hutter, K. Renner, G. Pfister, P. Stockl, P. Jansen-Durr and E. Gnaiger, Senescence-associated changes in respiration and oxidative phosphorylation in primary human fibroblasts, Biochem J 380 (2004), 919-928.
57. B.A. in t' Veld, A. Ruitenberg, A. Hofman, L.J. Launer, C.M. van Duijn, T. Stijnen, M.M. Breteler and B.H. Stricker, Non-steroidal antiinflammatory drugs and the risk of Alzheimer's disease, N Engl J Med 345 (2001), 1515-1521.
58. A.D. Inglot, M. Janusz and J. Lisowski, Colostrinine: a proline-rich polypeptide from ovine colostrum is a modest cytokine inducer in human leukocytes, Arch Immunol Ther Exp (Warsz) 44 (1996), 215-224.
59. M. Jamaluddin, S. Wang, I. Boldogh, B. Tian and A.R. Brasier, TNF-alpha-induced NF-kappaB/RelA Ser(276), phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway, Cell Signal 19 (2007), 1419-1433.
60. M. Janusz and J. Lisowski, Proline-rich polypeptide (PRP)-an immunomodulatory peptide from ovine colostrum, Arch Immunol Ther Exp (Warsz) 41 (1993), 275-279.
61. M. Janusz, J. Lisowski and F. Franek, Isolation and characterization of a proline-rich polypeptide from ovine colostrum, FEBS Lett 49 (1974), 276-279.
62. M. Janusz, K. Staroscik, M. Zimecki, Z. Wieczorek and J. Lisowski, Chemical and physical characterization of a proline-rich polypeptide from sheep colostrum, Biochem J 199 (1981), 9-15.
63. M. Janusz, K. Staroscik, M. Zimecki, Z. Wieczorek and J. Lisowski, Physicochemical properties of a proline-rich polypeptide (PRP), from ovine colostrum, Arch Immunol Ther Exp (Warsz) 26 (1978), 17-21.
64. M.H. Julius, M. Janusz and J. Lisowski, A colostral protein that induces the growth and differentiation of resting B lymphocytes, J Immunol 140 (1988), 1366-1371.
65. R. Katzman and T. Saitoh, Advances in Alzheimer's disease, FASEB J 5 (1991), 278-286.
66. H.F. Kauffman, J.F. Tomee, M.A. van de Riet, A.J. Timmerman and P. Borger, Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production, J Allergy Clin Immunol 105 (2000), 1185-1193.
67. M.R. Kelley and S.H. Parsons, Redox regulation of the DNA repair function of the human AP endonuclease Ape1/ref-1, Antioxid Redox Signal 3 (2001), 671-683.
68. D. Kelly and A.G. Coutts, Early nutrition and the development of immune function in the neonate, Proc Nutr Soc 59 (2000), 177-185.
69. P.J. Kolari, J. Lauharanta and M. Hoikkala, Midsummer solar UV-radiation in Finland compared with the UV-radiation from phototherapeutic devices measured by different techniques, Photodermatol 3 (1986), 340-345.
70. H. Korhonen and A. Pihlanto, Food-derived bioactive peptides - opportunities for designing future foods, Curr Pharm Des 9 (2003), 1297-1308.
71. M. Kruzel, M. Janusz, J. Lisowski, R. Fischleigh and J.A. Georgiades, Towards an understanding of biological role of colostrinin peptides, J Mol Neurosci 17 (2001), 115-125.
72. M.L. Kruzel, A. Polanowski, T. Wilusz, A. Sokolowska, M. Pacewicz, R. Bednarz and J.A. Georgiades, The alcohol-induced conformational changes in casein micelles: a new challenge for the purification of colostrinin, Protein J 23 (2004), 127-133.
73. P.T. Lansbury Jr., Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease, Proc Natl Acad Sci USA 96 (1999), 3342-3344.
74. M. Larche, D.S. Robinson and A.B. Kay, The role of T lymphocytes in the pathogenesis of asthma, J Allergy Clin Immunol 111 (2003), 450-463; quiz 464.
75. F.C. Lau, B. Shukitt-Hale and J.A. Joseph, Nutritional intervention in brain aging: reducing the effects of inflammation and oxidative stress, Subcell Biochem 42 (2007), 299-318.
76. G. Lenaz, C. Bovina, M. D'Aurelio, R. Fato, G. Formiggini, M.L. Genova, G. Giuliano, M. Merlo Pich, U. Paolucci, G. Parenti Castelli and B. Ventura, Role of mitochondria in oxidative stress and aging, Ann N Y Acad Sci 959 (2002), 199-213.
77. G. Leonarduzzi, M.C. Arkan, H. Basaga, E. Chiarpotto and A. Sevanian, Poli G. Lipid oxidation products in cell signaling, Free Radic Biol Med 28 (2000), 1370-1378.
78. J. Leszek, A.D. Inglot, M. Janusz, F. Byczkiewicz, A. Kiejna, J. Georgiades and J. Lisowski, Colostrinin proline-rich polypeptide complex from ovine colostrum - a long-term study of its efficacy in Alzheimer's disease, Med Sci Monit 8 (2002), PI93-PI96.
79. J. Leszek, A.D. Inglot, M. Janusz, J. Lisowski, K. Krukowska, J.A. Georgiades, Colostrinin: a proline-rich polypeptide (PRP), complex isolated from ovine colostrum for treatment of Alzheimer's disease. A double-blind, placebo-controlled study, Arch Immunol Ther Exp (Warsz) 47 (1999), 377-385.
80. A. Levi, S. Biocca, A. Cattaneo and P. Calissano, The mode of action of nerve growth factor in PC12 cells, Mol Neurobiol 2 (1988), 201-226.
81. A.J. Levine, p53, the cellular gatekeeper for growth and division, Cell 88 (1997), 323-331.
82. R.D. Ley, Ultraviolet radiation A-induced precursors of cutaneous melanoma in Monodelphis domestica, Cancer Res 57 (1997), 3682-3684.
83. W.F. Li, G.X. Ma and X.X. Zhou, Apidaecin-type peptides: biodiversity, structure-function relationships and mode of action, Peptides 27 (2006), 2350-2359.
84. D.A. Liebermann, B. Hoffman and R.A. Steinman, Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways, Oncogene 11 (1995), 199-210.
85. M. Loscertales, S.P. Rose, J.N. Daisley and C. Sandi, Piracetam facilitates long-term memory for a passive avoidance task in chicks through a mechanism that requires a brain corticosteroid action, Eur J Neurosci 10 (1998), 2238-2243.
86. J.C. Mak, Chan-Yeung M. M. Reactive oxidant species in asthma, Curr Opin Pulm Med 12 (2006), 7-11.
87. B. Manavathi, S.S. Nair, R.A. Wang, R.Kumar and R.K. Vadlamudi, Proline-, glutamic acid-, and leucine-rich protein-1 is essential in growth factor regulation of signal transducers and activators of transcription 3 activation, Cancer Res 65 (2005), 5571-5577.
88. L. Marek, V. Levresse, C. Amura, E. Zentrich, V. Van Putten, R.A. Nemenoff and L.E. Heasley, Multiple signaling conduits regulate global differentiation-specific gene expression in PC12 cells, J Cell Physiol 201 (2004), 459-469.
89. G.P. Margison, A.C. Povey, B. Kaina and M.F. Santibanez Koref, Variability and regulation of O6-alkylguanine-DNA alkyltransferase. Carcinogenesis 24 (2003), 625-635.
90. D. Meloni, G.R. Casale, A.M. Siani, S. Palmieri and F. Cappellani, Solar UV dose patterns in Italy, Photochem Photobiol 71 (2000), 681-690.
91. S. Mitra, T. Izumi, I. Boldogh, K.K. Bhakat, J.W. Hill and T.K. Hazra, Choreography of oxidative damage repair in mammalian genomes, Free Radic Biol Med 33 (2002), 15-28.
92. H. Miwa, M. Iijima, S. Tanaka and Y. Mizuno, Generalized convulsions after consuming a large amount of gingko nuts, Epilepsia 42 (2001), 280-281.
93. T.R. Mosmann, H. Cherwinski, M.W. Bond, M.A. Giedlin and R.L. Coffman, Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins, J Immunol 136 (1986), 2348-2357.
94. H. Nishina, T. Wada and T. Katada, Physiological roles of SAPK/JNK signaling pathway, J Biochem (Tokyo) 136 (2004), 123-126.
95. M. Ott, V. Gogvadze, S. Orrenius and B. Zhivotovsky, Mitochondria, oxidative stress and cell death, Apoptosis 12 (2007), 913-922.
96. M.S. Parihar and G.J. Brewer, Mitoenergetic Failure in Alzheimer Disease. Am J Physiol Cell Physiol 292 (2007), C8-C23.
97. M.H. Pittler and E. Ernst, Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials, Am J Med 108 (2000), 276-281.
98. W. Poluha, C.M. Schonhoff, K.S. Harrington, M.B. Lachyankar, N.E. Crosbie, D.A. Bulseco and A.H. Ross, A novel, nerve growth factor-activated pathway involving nitric oxide, p53, and p21WAF1 regulates neuronal differentiation of PC12 cells, J Biol Chem 272 (1997), 24002-24007.
99. P. Popik, B. Bobula, M. Janusz, J. Lisowski and J. Vetulani, Colostrinin, a polypeptide isolated fromearly milk, facilitates learning and memory in rats, Pharmacol Biochem Behav 64 (1999), 183-189.
100. P. Popik, Z. Galoch, M. Janusz, J. Lisowski and J. Vetulani, Cognitive effects of Colostral-Val nonapeptide in aged rats, Behav Brain Res 118 (2001), 201-208.
101. C.V. Ramana, I. Boldogh, T. Izumi and S. Mitra, Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals, Proc Natl Acad Sci USA 95 (1998), 5061-5066.
102. H. Renz, G. Lack, J. Saloga, R. Schwinzer, K. Bradley, J. Loader, A. Kupfer, G.L. Larsen and E.W. Gelfand, Inhibition of IgE production and normalization of airways responsiveness by sensitized CD8 T cells in a mouse model of allergen-induced sensitization, J Immunol 152 (1994), 351-360.
103. U. Riese, E. Ziegler and M. Hamburger, Militarinone A induces differentiation in PC12 cells via MAP and Akt kinase signal transduction pathways, FEBS Lett 577 (2004), 455-459.
104. J. Rogers, D. Mastroeni, B. Leonard, J. Joyce and A. Grover, Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder? Int Rev Neurobiol 82 (2007), 235-246.
105. S.P. Rose and M.G. Stewart, Cellular correlates of stages of memory formation in the chick following passive avoidance training, Behav Brain Res 98 (1999), 237-243.
106. C. Sandi, S.P. Rose, R. Mileusnic and C. Lancashire, Corticosterone facilitates long-term memory formation via enhanced glycoprotein synthesis, Neuroscience 69 (1995), 1087-1093.
107. S. Scharf, A. Mander, A. Ugoni, F. Vajda and N. Christophidis, A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease, Neurology 53 (1999), 197-201.
108. D. Schenk, R. Barbour, W. Dunn, G. Gordon, H. Grajeda, T. Guido, K. Hu, J. Huang, K. Johnson-Wood, K. Khan, D. Kholodenko, M. Lee, Z. Liao, I. Lieberburg, R. Motter, L. Mutter, F. Soriano, G. Shopp, N. Vasquez, C. Vandevert, S. Walker, M. Wogulis, T. Yednock, D. Games and P. Seubert, Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse, Nature 400 (1999), 173-177.
109. D. Schuster, A. Rajendran, S.W. Hui, T. Nicotera, T. Srikrishnan and M.L. Kruzel, Protective effect of colostrinin on neuroblastoma cell survival is due to reduced aggregation of beta-amyloid, Neuropeptides 39 (2005), 419-426.
110. D.J. Selkoe, Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81 (2001), 741-766.
111. R.B. Setlow, E. Grist, K. Thompson and A.D. Woodhead, Wavelengths effective in induction of malignant melanoma, Proc Natl Acad Sci USA 90 (1993), 6666-6670.
112. G. Shaulsky, N. Goldfinger, A. Peled and V. Rotter, Involvement of wild-type p53 protein in the cell cycle requires nuclear localization, Cell Growth Differ 2 (1991), 661-667.
113. M.K. Shigenaga, T.M. Hagen and B.N. Ames, Oxidative damage and mitochondrial decay in aging, Proc Natl Acad Sci USA 91 (1994), 10771-10778.
114. W. Siems, S. Quast, F. Carluccio, I. Wiswedel, D. Hirsch, W. Augustin, H. Hampi, M. Riehle and O. Sommerburg, Oxidative stress in chronic renal failure as a cardiovascular risk factor, Clin Nephrol 58 Suppl 1 (2002), S12-S19.
115. G.W. Small, P.V. Rabins, P.P. Barry, N.S. Buckholtz, S.T. DeKosky, S.H. Ferris, S.I. Finkel, L.P. Gwyther, Z.S. Khachaturian, B.D. Lebowitz, T.D. McRae, J.C. Morris, F. Oakley, L.S. Schneider, J.E. Streim, T. Sunderland, L.A. Teri and L.E. Tune, Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society, Jama 278 (1997), 1363-1371.
116. A. Solokowska, R. Bernadz, M. Pacewicz, JA. Georgiades, T. Wilnusx and A. Polanowski, Colostrum from different mammalian species -A rich source of colostrinin, Int Dairy J (2008), (In Press).
117. J. Stanton, I. Boldogh, J.A. Georgiades and T.K. Hughes, Induction of proliferation and cytokines by colostrinin and component proline rich peptides in human periferal blood leukocytes, Psychogeriatr Ann 4 (2001), 67-75.
118. R.J. Steele, C.R. Dermon and M.G. Stewart, D-cycloserine causes transient enhancement of memory for a weak aversive stimulus in day-old chicks (Gallus domesticus), Neurobiol Learn Mem 66 (1996), 236-240.
119. M.G. Stewart and D. Banks, Enhancement of long-term memory retention by Colostrinin in one-day-old chicks trained on a weak passive avoidance learning paradigm, Neurobiol Learn Mem 86 (2006), 66-71.
120. W.F. Stewart, C. Kawas, M. Corrada and E.J. Metter, Risk of Alzheimer's disease and duration of NSAID use, Neurology 48 (1997), 626-632.
121. T. Takeda, M. Hosokawa and K. Higuchi, Senescence-accelerated mouse (SAM): a novel murine model of senescence, Exp Gerontol 32 (1997), 105-109.
122. P. Taramarcaz, B. Lambelet, B. Clot, C. Keimer and C. Hauser, Ragweed (Ambrosia), progression and its health risks: will Switzerland resist this invasion? Swiss Med Wkly 135 (2005), 538-548.
123. E.R. Tovey, M.D. Chapman and T.A. Platts-Mills, Mite faeces are a major source of house dust allergens, Nature 289 (1981), 592-593.
124. D.T. Umetsu and R.H. Dekruyff, Immune dysregulation in asthma, Curr Opin Immunol 18 (2006), 727-732.
125. L.J. Van Eldik, W.L. Thompson, H. Ralay Ranaivo and H.A. Behanna, Martin Watterson D. Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: function-based and target-based discovery approaches, Int Rev Neurobiol 82 (2007), 277-296.
126. D. Vaudry, P.J. Stork, P. Lazarovici and L.E. Eiden, Signaling pathways for PC12 cell differentiation: making the right connections, Science 296 (2002), 1648-1649.
127. D.M. Walsh and D.J. Selkoe, A beta oligomers - a decade of discovery, J Neurochem 101 (2007), 1172-1184.
128. R.L. Wells and A. Han, Action spectra for killing and mutation of Chinese hamster cells exposed to mid- and near-ultraviolet monochromatic light, Mutat Res 129 (1984), 251-258.
129. Z. Wieczorek, M. Zimecki, M. Janusz, K. Staroscik and J. Lisowski, Proline-rich polypeptide from ovine colostrum: its effect on skin permeability and on the immune response, Immunology 36 (1979), 875-881.
130. M.P. Williamson, The structure and function of proline-rich regions in proteins, Biochem J 297(Pt 2) (1994), 249-260.
131. K.W. Wood, C. Sarnecki, T.M. Roberts and J. Blenis, ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK, Cell 68 (1992), 1041-1050.
132. N. Wopfner, G. Gadermaier, M. Egger, R. Asero, C. Ebner, B. Jahn-Schmid and F. Ferreira The spectrum of allergens in ragweed and mugwort pollen, Int Arch Allergy Immunol 138 (2005), 337-346.
133. J. Xiao and Y. Liu, Differential roles of ERK and JNK in early and late stages of neuritogenesis: a study in a novel PC12 model system, J Neurochem 86 (2003), 1516-1523.
134. A. Zablocka, M. Janusz, J. Macala and J. Lisowski, A proline-rich polypeptide complex (PRP), isolated from ovine colostrum. Modulation of H(2)O(2), and cytokine induction in human leukocytes, Int Immunopharmacol 7 (2007), 981-988.
135. A. Zablocka, M. Janusz, J. Macala and J. Lisowski, A proline-rich polypeptide complex and its nonapeptide fragment inhibit nitric oxide production induced in mice, Regul Pept 125 (2005), 35-39.
136. A. Zablocka, M. Janusz, K. Rybka, I. Wirkus-Romanowska, G.Kupryszewski and J. Lisowski, Cytokine-inducing activity of a proline-rich polypeptide complex (PRP), from ovine colostrum and its active nonapeptide fragment analogs, Eur Cytokine Netw 12 (2001), 462-467.
137. W. Zhong, T. Yan, M.M. Webber and T.D. Oberley, Alteration of cellular phenotype and responses to oxidative stress by manganese superoxide dismutase and a superoxide dismutase mimic in RWPE-2 human prostate adenocarcinoma cells, Antioxid Redox Signal 6 (2004), 513-522.
138. M. Zimecki, T. Hraba, M. Janusz, J. Lisowski AMD Z. Wieczorek, Effect of a proline-rich polypeptide (PRP), on the development of hemolytic anemia and survival of New Zealand black (NZB), mice, Arch Immunol Ther Exp (Warsz) 39 (1991), 461-467.
139. M. Zimecki, M. Janusz, K. Staroscik, Z. Wieczorek and J. Lisowski, Immunological activity of a proline-rich polypeptide from ovine colostrum. Arch Immunol Ther Exp (Warsz) 26 (1978), 23-29.
140. M. Zimecki and M.L. Kruzel, Milk-derived proteins and peptides of potential therapeutic and nutritive value, J Exp Ther Oncol 6 (2007), 89-106.
141. M. Zimecki, J. Lisowski, T. Hraba, Z. Wieczorek, M. Janusz and K. Staroscik, The effect of a proline-rich polypeptide (PRP), on the humoral immune response. I. Distinct effect of PRP on the T cell properties of mouse glass-nonadherent (NAT), and glass-adherent (GAT), thymocytes in thymectomized mice, Arch Immunol Ther Exp (Warsz) 32 (1984), 191-196.
142. M. Zimecki, J. Lisowski, T. Hraba, Z. Wieczorek, M. Janusz and K. Staroscik, The effect of a proline-rich polypeptide (PRP), on the humoral immune response. II. PRP induces differentiation of helper cells from glass-nonadherent thymocytes (NAT), and suppressor cells from glass-adherent thymocytes (GAT), Arch Immunol Ther Exp (Warsz) 32 (1984), 197-201.